Duodenoscope Culture Methods Update

Similar documents
Babies, and Biofilms: An Outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit

Discussions and Activity at the Federal Level Regarding Management of Electronic Medical Equipment

5/9/17. Healthcare-Associated Infections Cultural Shift. Background. Disclosures and Disclaimers

Enterobacteriaceae. Preventing the Spread of Carbapenemresistant. in LTCFs. Nimalie D. Sto ne, MD, MS CDC Division of Healthcare Quality Promotion

USING PROCESS EVALUATION TO INFORM PROGRAM DESIGN. A CASE STUDY OF THE EBOLA RESPONSE IN THE U.S. HEALTHCARE SYSTEM Monica LaBelle, PhD

Infection Prevention and Control in Ambulatory Care Settings: Minimum Expectations for Safe Care

2016 Sterilization Standards Update

New SGNA Standards Call for Expanded Infection Prevention Efforts in GI Endoscopy

Assessing Evidence of Transmission and End of Transmission of Carbapenemase Producing Enterobacterales 1 (CPE)

Core Elements of Antibiotic Stewardship for Nursing Homes

Advancing Biosafety Across the U.S. Clinical Laboratory Community

Endoscope Reprocessing

Division of Laboratory Systems Protecting America s Health by Strengthening Clinical and Public Health Laboratories

ENDOSCOPY MICROBIOLOGY ALERTS PROCEDURE STANDARD OPERATING PROCEDURE

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 3 Strategies to prevent

Sterile Processing in Healthcare Facilities

INFECTION CONTROL TRAINING CENTERS

9/14/2017. Best Practices in Instrument Cleaning. Objectives. Healthcare-associated Infections

Outbreak Management it takes a village. November 20, 2014 Linda Stein Marge Gribogiannis

Healthcare Antibiotic Resistance Prevalence DC (HARP-DC)

10/18/2010. Disclosure. Learning Objectives. Components of an Effective Infection Control Program

Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE) 2012 CRE Toolkit

May 9, Leslie Kux Associate Commissioner for Policy U.S. Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852

EBOLA PREPAREDNESS TOOL FOR EBOLA TREATMENT CENTERS AND ASSESSMENT HOSPITALS

Nosocomial Infection in a Teaching Hospital in Thailand

ENDOSCOPE PROTEIN RESIDUE TESTING STANDARD OPERATING PROCEDURE

Carbapenamase Producing Enterobacteriaceae: A Draining Concern

IHI Expedition. Antibiotic Stewardship Session 2: Promoting a Culture for Optimal Antibiotic Use. April 3, Diane Jacobsen, MPH Loria Pollack, MD

AS/NZS 4187:2003 AS/NZS

A REVIEW OF ENVIRONMENTAL HYGIENE REQUIREMENTS

Jeanne Moldenhauer (c) Jeanne Moldenhauer

Strengthening a Culture of Laboratory Safety

Implementing Technologies for the Reduction of Hospital Acquired Infections. AHCA 2015 October 12, 2015 / 1:00 2:00 pm

Multi-Link. X2 ECG System. Choose flexibility and quality for your reusable and disposable single-patient-use leadwires

Infection Prevention Checklist Section I: Policies and Practices I.1 Administrative Measures

Health Care Associated Infections in 2015 Acute Care Hospitals

INFECTION C ONTROL CONTROL CONTROL EDUCATION PROGRAM

Charles Hughes. Instrument Reprocessing Update: What s New?

San Francisco General Hospital INFECTION CONTROL

INFECTION CONTROL SURVEYOR WORKSHEET

Infection Prevention and Control Training

The Role of Isolation and Contact Precautions in the Elimination of Transmission of MRSA

The potential role of X ray technicians and mobile radiography. equipment in the transmission of multi-resistant drug resistant bacteria

Infectious Diseases-HAI, Infectious Diseases Connecticut Department of Public Health, Infectious Disease: Healthcare Associated Infections, STD/TB

Joint Commission NPSG 7: 2011 Update and 2012 Preview

Evaluation of State Public Health Actions: Overview and Progress to Date Rachel Davis, MPH

HOW CLEAN IS CLEAN? STRATEGIES FOR ENVIRONMENTAL CLEANLINESS IN THE AMBULATORY SETTING

Infectious Diseases- HAI Tennessee Department of Health, Healthcare Associated Infections and Antimicrobial Resistance Program/ CEDEP

ROUNDTABLE: HOSPITAL ADMINISTRATIVE DATA STEWARDSHIP

Control Practices for. Mary McGoldrick, MS, RN, CRNI

Speaker Declarations

REGULATORY & ACCREDITING AGENCIES

Healthcare-Associated Infections in U.S. Nursing Homes: Results from a Prevalence Survey Pilot

Take Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home

1/28/2014. Take Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home. Thank you to AANAC

Infection Prevention, Control & Immunizations

NJ Dept of Health Central Service Standards SUBCHAPTER 8. CENTRAL SERVICE. 8:43G-8.1 Central service policies and procedures

Infection Prevention and Control

NSQHS Standard 3: How are we going?

Your Act! MRSA, C. diff, other harmful bacteria lurk in unexpected places

Presented by: Mary McGoldrick, MS, RN, CRNI

DIRTY SCOPES: What You Need to Know About the New Reprocessing Guidelines and Infection Risk

Clinical Guidance on the Identification and Evaluation of Possible SARS-CoV Disease among Persons Presenting with Community-Acquired Illness Version 2

Carbapenemase producing. Carbapenem Resistant Enterobacteriaceae. (CRE) in Critical Care Units in Ireland: A National Pilot Study June 2011

Infection prevention & control

Our Speaker / Faculty 2016 Infection Prevention Strategies for ASC s

Billing Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [30Day ]

Laboratory-Clinician Communication Wednesday, September 16, :30 2:20 PM. John A. Vanchiere, M.D., Ph.D.

Risk Assessment Tool for Infection Surveillance, Prevention and Control Programs In Ambulatory Healthcare Settings

Infection Prevention and Control (IPC) Elements of an Effective Program

Frequently Asked Questions. Last updated: 17/11/10

Proactively prevent HAIs with infection surveillance software

NOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION

APPLICATION. Thank you for your interest in applying for the APIC Program of Distinction.

BUGS BE GONE: Reducing HAIs and Streamlining Care!

Hosted by Paul Webber A Webber Training Teleclass 1

Local Health Department Access to the National Healthcare Safety Network. January 23, 2018

PROCESS IMPROVEMENT AND ENHANCED QUALITY CARE ARE THE

August 28, Dear Ms. Tavenner:

Update on Premarket Notification Requirements Concerning Gowns Intended for Use in Health Care

Objectives. Hot Topics in Infection Prevention and Control in Post Acute Care Settings. NADONA Infection Prevention and Control Webinar Series

Endoscopy Center Design and Practice

Ambulatory Surgical Center (ASC) INFECTION CONTROL SURVEYOR WORKSHEET

The Use of NHSN in HAI Surveillance and Prevention

Session 1 Establishing Access through Secure Access Management Services (SAMS) for Long-term Care Facility (LTCF) Users

Surgical Site Infection Prevention: Guidelines, Recommendations and Best Practice

Infection Prevention and Control and Antibiotic Stewardship: More than Counting Beans

NHS GREATER GLASGOW & CLYDE STANDARD OPERATING PROCEDURE (SOP)

New Jersey State Department of Health and Senior Services Healthcare-Associated Infections Plan 2010

Report of the unannounced inspection at Wexford General Hospital.

Standard of Infection Prevention in the Gastroenterology Setting

Requirements for Screening of Patients for Carbapenemase-Producing Enterobacteriales (CPE) 1 in the Acute Hospital Sector CPE Expert Group

Carbapenemase-producing Enterobacteriaceae (CPE) in HSE acute hospitals in Ireland monthly report December 2017

ESRD Network 5: Prevention Process Measure Training Christi Lines, MPH

Infection Prevention Challenges in the Ambulatory Surgery Center : Strategies for a Successful CMS Survey

Sterile Processing: Preparing for Accreditation Surveys. Monday, March 4, 2013, 8-9am & 9:30-10:30am

Surveillance Protocol for Carbapenemase- Producing Organisms (CPO) in British Columbia

MILITARY MEDICINE, 174, 9:899, 2009

APIC Fellow. In May 2016, I was notified that I had been selected to be in the. Becoming an

INFECTION CONTROL SURVEILLANCE POLICY

Transcription:

Duodenoscope Culture Methods Update Angela Coulliette-Salmond, Ph.D. Division of Healthcare Quality and Promotion, Clinical and Environmental Microbiology Branch HICPAC, Session on Medical Device Reprocessing July 16, 2015 National Center for Emerging and Zoonotic Infectious Diseases U.S. Centers for Disease Control and Prevention

CEMB Organization Matt Arduino, DrPH Branch chief Brandi Limbago, PhD Deputy Branch Chief Lee Lam, PMO Sigrid McAllister, Quality Manager Advanced Molecular Detection Judith Noble-Wang, PhD Lead, Environmental & Applied Microbiology J. Kamile Rasheed, PhD Lead, Antimicrobial Resistance & Characterization Laboratory Biofilm laboratory Reference laboratory Outbreak support Gram-negative surveillance Healthcare Environment research Gram-positive surveillance

Environmental and Applied Microbiology Laboratory

http://www.cdc.gov/hai/organisms/cre/cre-duodenoscope-surveillance-protocol.html

Timeline 2013 2014 N M J M J 2015 F

CEMB Duodenoscope Activities Protocol development IL and WA outbreak response Literature review, SME feedback Stakeholder engagement Discussions with facilities, societies, federal agencies Feedback to CDC INFO Amended protocols, developed Frequently Asked Questions (FAQs)

Protocol development IL Outbreak Response 39 case patients: NDM-producing E. coli Initial protocols used to extract bacteria from duodenoscope Devices were sent to the CDC CEMB laboratory More rigorous methods: broth, brushes, sonication Recovered from duodenoscope: KPC+ K. pneumonia, NDM-producing E. coli Epstein et al. 2015, JAMA, 312(14):1447

Protocol development WA outbreak response 32 case patient and 4 of 8 duodenoscopes: multidrug resistant E. coli (hyper ampc) EIS Officers deployed, targeted protocol refined for facilities in mind Methods: targeted individual samples, PBST, sterile water, swab/brush combination, samples shipped to the CDC CEMB laboratory Study, only detected gram-positive bacteria Ross et al. 2015, Gasto Endoscopy, Article in Press

Protocol Development Historic Literature 1970 Flushing channels with sterile saline or water to culture was common practice Bond and Moncada (1978) used swab to sample the distal end and other endoscope surfaces 1980 First published validated procedure for sampling endoscopes was published, used flush and swab samples (Hanson et al. 1989, 1990) 1990 Alfa et al. (1991) utilized the Hanson et al. model for sampling duodenoscopes to assess drying Approach was adjusted to passing a brush up/down the channels and sterile water flush (Alfa et al. 1999)

Protocol Development Literature Review Sampling location Channel (20 studies), elevator guide wire (3 studies), distal end (3 studies) Sampling technique Flush (16 studies) Brush (8 studies) or swab (2 studies) Combined (2 studies) Sampling media sterile/ro/di water (9 studies) and saline (7 studies)

Protocol Development Literature Review Concentration of samples to detect low numbers, centrifugation (3 studies) or membrane filtration (2 studies) Plating/ Culture media Blood (16 studies), MacConkey (9 studies) Counted (CFU) (15 studies) or presence (pos/neg)(4 studies) Common bacteria detected Majority: Pseudomonas (14 studies), Staphylococcus (15 studies) Klebsiella, Acinetobacter (7 studies)

I. Sampling Protocol Development Current Status II. Culturing - Agitated, concentrated - Cultured - Focused on high-concern organisms III. Algorithm - Interpretation/Remedial Actions - Criterion for low-concern, action level >10 CFU per scope - Criterion for high-concern, 0 CFU https://catalog.hardydiagnostics.com/cp_prod/content/pdf/duodenoscope_infographic.pdf

EIN Duodenoscope Survey March 30 to April 22, 2015 378/699 physicians responded (Infection Control, SHEA members) 31% - no cultures, surveillance cultures, clinical cultures Number of respondents Culture method 17 Interim CDC Recommendations (March 2015) 4 Other methods: (a) Flush-Brush-Flush (Aumeran C, et al. Endoscopy 2010, 42(11):895-9); (b) Clinical Micro Procedures Handbook by HD Isenberg; (c) modified Australian procedure 2 Virginia Mason Protocol 26 Flushed fluid down the channels and cultured fluid 6 Various methods from brushing, swabbing elevator, to flushing channels

Stakeholder Engagement Regulator/ Standards FDA, CMS, AAMI Healthcare Patients, MD s, Nurses Device ERCP Manufacturer s Olympus, FUJI, Pentax Agencies/Societies ASGE, SGNA, AGA, APIC, ASM CDC DHQP, CEMB lab Reprocessing Nurses, Technicians, Infection Control Clinical laboratories

Stakeholder Engagement Regulator/ Standards FDA, CMS, AAMI Healthcare Patients, MD s, Nurses CDC INFO, Device FAQs ERCP Manufacturer s Olympus, FUJI, Pentax Agencies/Societies ASGE, SGNA, AGA, APIC, ASM Update protocols CDC DHQP, CEMB lab Reprocessing Nurses, Technicians, Infection Control Clinical laboratories

Stakeholder Engagement Regulator/ Standards FDA, CMS, AAMI Healthcare Patients, MD s, Nurses Agencies/Societies ASGE, SGNA, AGA, APIC, ASM Device ERCP Duodenoscope surveillance experience and pilot study interests CDC DHQP, CEMB lab Manufacturer s Olympus, FUJI, Pentax Reprocessing Nurses, Technicians, Infection Control Clinical laboratories

Stakeholder Engagement Regulator/ Standards FDA, CMS, AAMI Healthcare Patients, MD s, Nurses ID and assist Agencies/Societies facilities with ASGE, handling SGNA, AGA, transmission APIC, ASM clusters Device ERCP CDC DHQP, CEMB lab Manufacturer s Olympus, FUJI, Pentax Reprocessing Nurses, Technicians, Infection Control Clinical laboratories

Stakeholder Engagement Healthcare Patients, MD s, Nurses Agencies/Societies ASGE, SGNA, AGA, APIC, ASM Regulator/ Standards FDA, CMS, AAMI Device ERCP CDC DHQP, CEMB lab Provide Manufacturer s environmental Olympus, laboratory FUJI, assistance Pentax Reprocessing Nurses, Technicians, Infection Control Clinical laboratories

Coming Soon Amended protocols, developed FAQs

Moving Forward FDA (March 2015), recommendations for the formulations and scientific validation of reprocessing instructions for reusable medical devices Quality control issues Limitations validation, unknown baseline, cost, notification FDA-led duodenoscope working group FDA, March 2015: http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm253010.pdf Olympus, March 2015: http://medical.olympusamerica.com/sites/default/files/pdf/150326_tjf-q180v_customer_letter.pdf

For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA 30333 Telephone, 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348 E-mail: cdcinfo@cdc.gov Web: www.cdc.gov The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

References 1. Moses, F.M. and J. Lee. 2003. Am J Gastroenterol. 98(1):77-81. 2. Chiu et al. 2010. Hepato-Gastroenterol. 57:531-534. 3. Bordas et al. 2005. Hepato-Gastroenterol. 52:800-807. 4. Brock et al. 2014. Gastrointest Endosc. In Press. http://dx.doi.org/10.1016/j.gie.2014.09.053 5. Chiu et al. 2012. BMC Gasterenterol. 12:120. 6. Ingram et al. 2013. Gastroenterol Nurs. 36(2):106-111. 7. Pang et al. 2002. Gastrointest Endosc. 56(3):402-406. 8. Vergis et al. 2007. Endoscopy. 39:737-739. 9. Alfa M.J. and D.L. Sitter. 1991. J Hosp Infect. 19:89-98. 10. Alfa et al. 2002. Infect Cont Hosp Ep. 23(4):198-206. 11. Alfa et al. 2012. Am J Infect Control. 40:233-236. 12. Grandval et al. 2013. J Hosp Infect. 84:71-76. 13. Osborne et al. 2007. Endosc. 39:825-830. 14.Kim et al. 2011. Clin Endosc. 44:109-115. 15.Bisset et al. 2006. Am J Infect Control. 34:274-280. 16.Deva et al. 1998. J Hosp Infect. 39:149-157. 17. Alfa et al. 2014. Am J Infect Control. 42:e1-e5. 18.Riley et al. 2002. Gastroenterol Nurs. 25(3):114-119. 19. Gillespie et al. 2008. J Gasteroenterol Hepato. 23:1069-1074. 20.Hanson et al. 1990. Gut. 31:657-659. 21. Alfa et al. 2012. Am J Infect Control. 40:860-865 22. Queensland Health, https://www.health.qld.gov.au/endoscopereprocessing/module_6/6_4.asp